These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11176455)

  • 1. Evaluation of gene transfer efficiency by viral vectors to murine bladder epithelium.
    Siemens DR; Austin JC; See WA; Tartaglia J; Ratliff TL
    J Urol; 2001 Feb; 165(2):667-71. PubMed ID: 11176455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of viral vectors: gene transfer efficiency and tissue specificity in a bladder cancer model.
    Siemens DR; Crist S; Austin JC; Tartaglia J; Ratliff T
    J Urol; 2003 Sep; 170(3):979-84. PubMed ID: 12913754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A system for the enhancement of adenovirus mediated gene transfer to uro-epithelium.
    Lin LF; Zhu G; Yoo JJ; Soker S; Sukhatme VP; Atala A
    J Urol; 2002 Aug; 168(2):813-8. PubMed ID: 12131373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo retroviral mediated gene transfer into bladder urothelium results in preferential transduction of tumoral cells.
    Dumey N; Mongiat-Artus P; Devauchelle P; Lesourd A; Cotard JP; Le Duc A; Marty M; Cussenot O; Cohen-Haguenauer O
    Eur Urol; 2005 Feb; 47(2):257-63. PubMed ID: 15661423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
    Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonviral cytokine gene therapy on an orthotopic bladder cancer model.
    Wu Q; Mahendran R; Esuvaranathan K
    Clin Cancer Res; 2003 Oct; 9(12):4522-8. PubMed ID: 14555526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute acrolein-induced cystitis in mice.
    Bjorling DE; Elkahwaji JE; Bushman W; Janda LM; Boldon K; Hopkins WJ; Wang ZY
    BJU Int; 2007 Jun; 99(6):1523-9. PubMed ID: 17346276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies.
    Watanabe T; Shinohara N; Sazawa A; Harabayashi T; Ogiso Y; Koyanagi T; Takiguchi M; Hashimoto A; Kuzumaki N; Yamashita M; Tanaka M; Grossman HB; Benedict WF
    Cancer Gene Ther; 2000 Dec; 7(12):1575-80. PubMed ID: 11228536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of pretreatment agents to enhance adenovirus infection of bladder epithelium.
    Ramesh N; Memarzadeh B; Ge Y; Frey D; VanRoey M; Rojas V; Yu DC
    Mol Ther; 2004 Oct; 10(4):697-705. PubMed ID: 15451454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of polyamides that enhance adenovirus-mediated gene expression in the urothelium.
    Connor RJ; Engler H; Machemer T; Philopena JM; Horn MT; Sutjipto S; Maneval DC; Youngster S; Chan TM; Bausch J; McAuliffe JP; Hindsgaul O; Nagabhushan TL
    Gene Ther; 2001 Jan; 8(1):41-8. PubMed ID: 11402300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vivo gene transfer methods into bladder without viral vectors].
    Sugimura K; Harimoto K; Kishimoto T
    Hinyokika Kiyo; 1997 Nov; 43(11):823-7. PubMed ID: 9436030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer.
    Hadaschik BA; Zhang K; So AI; Fazli L; Jia W; Bell JC; Gleave ME; Rennie PS
    Cancer Res; 2008 Jun; 68(12):4506-10. PubMed ID: 18559493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrodynamic plasmid DNA gene therapy model in liver transplantation.
    Tsoulfas G; Takahashi Y; Liu D; Yagnik G; Wu T; Murase N; Geller DA
    J Surg Res; 2006 Oct; 135(2):242-9. PubMed ID: 16926028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy.
    Pagliaro LC; Keyhani A; Williams D; Woods D; Liu B; Perrotte P; Slaton JW; Merritt JA; Grossman HB; Dinney CP
    J Clin Oncol; 2003 Jun; 21(12):2247-53. PubMed ID: 12805322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer.
    Yamashita M; Rosser CJ; Zhou JH; Zhang XQ; Connor RJ; Engler H; Maneval DC; Karashima T; Czerniak BA; Dinney CP; Benedict WF
    Cancer Gene Ther; 2002 Aug; 9(8):687-91. PubMed ID: 12136430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccinia virus mediated p53 gene therapy for bladder cancer in an orthotopic murine model.
    Fodor I; Timiryasova T; Denes B; Yoshida J; Ruckle H; Lilly M
    J Urol; 2005 Feb; 173(2):604-9. PubMed ID: 15643273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential gene transfer to BBN-induced rat bladder tumor by simple instillation of adenoviral vector.
    Shimizu H; Akasaka S; Suzuki S; Akimoto M; Shimada T
    Urology; 2001 Mar; 57(3):579-84. PubMed ID: 11248651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AdCD40L gene therapy counteracts T regulatory cells and cures aggressive tumors in an orthotopic bladder cancer model.
    Loskog AS; Fransson ME; Totterman TT
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8816-21. PubMed ID: 16361570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
    Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
    Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.